S

Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294

Watchlist Manager
Shenzhen Salubris Pharmaceuticals Co Ltd
SZSE:002294
Watchlist
Price: 31.18 CNY -1.64% Market Closed
Market Cap: 34.8B CNY
Have any thoughts about
Shenzhen Salubris Pharmaceuticals Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 26.5 CNY. Compared to the current market price of 31.18 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Overvalued by 15%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
26.5 CNY
Overvaluation 15%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation Backtest
Shenzhen Salubris Pharmaceuticals Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Shenzhen Salubris Pharmaceuticals Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Shenzhen Salubris Pharmaceuticals Co Ltd?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Shenzhen Salubris Pharmaceuticals Co Ltd

Provide an overview of the primary business activities
of Shenzhen Salubris Pharmaceuticals Co Ltd.

What unique competitive advantages
does Shenzhen Salubris Pharmaceuticals Co Ltd hold over its rivals?

What risks and challenges
does Shenzhen Salubris Pharmaceuticals Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide P/S
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide P/E
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide P/OCF
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide P/FCFE
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide P/B
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/S
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/GP
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/EBITDA
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/EBIT
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/OCF
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/FCFF
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide EV/IC
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Show me price targets
for Shenzhen Salubris Pharmaceuticals Co Ltd made by professional analysts.

What are the Revenue projections
for Shenzhen Salubris Pharmaceuticals Co Ltd?

How accurate were the past Revenue estimates
for Shenzhen Salubris Pharmaceuticals Co Ltd?

What are the Net Income projections
for Shenzhen Salubris Pharmaceuticals Co Ltd?

How accurate were the past Net Income estimates
for Shenzhen Salubris Pharmaceuticals Co Ltd?

What are the EPS projections
for Shenzhen Salubris Pharmaceuticals Co Ltd?

How accurate were the past EPS estimates
for Shenzhen Salubris Pharmaceuticals Co Ltd?

What are the EBIT projections
for Shenzhen Salubris Pharmaceuticals Co Ltd?

How accurate were the past EBIT estimates
for Shenzhen Salubris Pharmaceuticals Co Ltd?

Compare the revenue forecasts
for Shenzhen Salubris Pharmaceuticals Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shenzhen Salubris Pharmaceuticals Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shenzhen Salubris Pharmaceuticals Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shenzhen Salubris Pharmaceuticals Co Ltd compared to its peers.

Compare the P/E ratios
of Shenzhen Salubris Pharmaceuticals Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Shenzhen Salubris Pharmaceuticals Co Ltd with its peers.

Analyze the financial leverage
of Shenzhen Salubris Pharmaceuticals Co Ltd compared to its main competitors.

Show all profitability ratios
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide ROE
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide ROA
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide ROIC
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide ROCE
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Gross Margin
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Operating Margin
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Net Margin
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide FCF Margin
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Show all solvency ratios
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide D/E Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide D/A Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Interest Coverage Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Altman Z-Score Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Quick Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Current Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

Provide Cash Ratio
for Shenzhen Salubris Pharmaceuticals Co Ltd.

What is the historical Revenue growth
over the last 5 years for Shenzhen Salubris Pharmaceuticals Co Ltd?

What is the historical Net Income growth
over the last 5 years for Shenzhen Salubris Pharmaceuticals Co Ltd?

What is the current Free Cash Flow
of Shenzhen Salubris Pharmaceuticals Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shenzhen Salubris Pharmaceuticals Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shenzhen Salubris Pharmaceuticals Co Ltd

Current Assets 3.3B
Cash & Short-Term Investments 2.1B
Receivables 658m
Other Current Assets 532.1m
Non-Current Assets 6.3B
Long-Term Investments 1.8B
PP&E 1.4B
Intangibles 2.8B
Other Non-Current Assets 282.4m
Current Liabilities 1.2B
Accounts Payable 145.7m
Accrued Liabilities 584.9m
Short-Term Debt 35.3m
Other Current Liabilities 461.3m
Non-Current Liabilities 578.2m
Long-Term Debt 5m
Other Non-Current Liabilities 573.2m
Efficiency

Earnings Waterfall
Shenzhen Salubris Pharmaceuticals Co Ltd

Revenue
3.7B CNY
Cost of Revenue
-1.2B CNY
Gross Profit
2.6B CNY
Operating Expenses
-2B CNY
Operating Income
603.6m CNY
Other Expenses
-17.1m CNY
Net Income
586.5m CNY

Free Cash Flow Analysis
Shenzhen Salubris Pharmaceuticals Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Shenzhen Salubris Pharmaceuticals Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
58/100
Profitability
Score

Shenzhen Salubris Pharmaceuticals Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Shenzhen Salubris Pharmaceuticals Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Low D/E
84/100
Solvency
Score

Shenzhen Salubris Pharmaceuticals Co Ltd's solvency score is 84/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Shenzhen Salubris Pharmaceuticals Co Ltd

Wall Street analysts forecast Shenzhen Salubris Pharmaceuticals Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Salubris Pharmaceuticals Co Ltd is 37.74 CNY with a low forecast of 33.33 CNY and a high forecast of 43.05 CNY.

Lowest
Price Target
33.33 CNY
7% Upside
Average
Price Target
37.74 CNY
21% Upside
Highest
Price Target
43.05 CNY
38% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Shenzhen Salubris Pharmaceuticals Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Shenzhen Salubris Pharmaceuticals Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shenzhen Salubris Pharmaceuticals Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

34B CNY

Dividend Yield

1.6%

Description

Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of pharmaceuticals and medical devices. The company is headquartered in Shenzhen, Guangdong and currently employs 3,236 full-time employees. The company went IPO on 2009-09-10. The firm provides two categories of products: pharmaceutical preparation and bulk drugs. The firm is also engaged in the research and development, production and sales of cardiovascular medical devices. The firm distributes its products within domestic market and to overseas markets.

Contact

GUANGDONG
Shenzhen
37F, Main Building, NEO Square, Chegong Temple, No.6009 Shennan Avenue, Futian District
+8675583867888
www.salubris.cn

IPO

2009-09-10

Employees

3 236

Officers

GM & Director
Mr. Jie Yan
CFO, Accounting Supervisor & Financial Manager
Ms. Yun Kong
Secretary of the Board of Directors & Non Independent Director
Mr. Jianfeng Yang
Deputy General Manager
Ms. Song Ping Zhao
Chief Medical Officer
Dr. Xie Heng M.D., Ph.D.

See Also

Discover More
What is the Intrinsic Value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock?

The intrinsic value of one Shenzhen Salubris Pharmaceuticals Co Ltd stock under the Base Case scenario is 26.5 CNY.

Is Shenzhen Salubris Pharmaceuticals Co Ltd stock undervalued or overvalued?

Compared to the current market price of 31.18 CNY, Shenzhen Salubris Pharmaceuticals Co Ltd is Overvalued by 15%.

Back to Top